Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1160 of 1,261
  1. US 6692910

    Inhibition of a target messenger RNA with a modified U1 small nuclear RNA

    UNIVERSITY OF CONNECTICUT · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  2. US 6692750

    Alphavirus expression vector

    Bioption AB · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  3. US 6693183

    MURINE &agr; (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  4. US 6692964

    Methods for transfecting T cells

    United States of America as represented by the Secretary of the Air Force · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  5. US 6693103

    1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  6. US 6689864

    Cyclin dependent kinase 4 inhibitor

    The Regents of the University of California · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  7. US 6689784

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  8. US 6689767

    Triterpenes having antibacterial activity

    Regents of the University of Minnesota · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  9. US 6689878

    Target of RNAIII activating protein (TRAP)

    The Regents of the University of California · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  10. US 6689561

    Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

    The Regents of the University of California · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  11. US 6689775

    Uses of thioredoxin

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  12. US 6689575

    I&kgr;B kinase, subunits thereof, and methods of using same

    The Regents of the University of California · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  13. US 6689560

    Raf protein kinase therapeutics

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  14. US 6689362

    Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

    Regents of the University of Minnesota · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  15. US 6689384

    Stable pergolide mesylate and process for making same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  16. US 6689367

    Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  17. US 6689383

    Chromium-histidine complexes as nutrient supplements

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  18. US 6689338

    Bioconjugates of nanoparticles as radiopharmaceuticals

    The Board of Regents for Oklahoma State University · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  19. US 6689404

    Agent for regulating iodine exchange or for preventing iodine-deficit conditions

    Obschestvo S Ogranichenoi Otvetstvennostou “Medbiofarm” · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  20. US 6689778

    Inhibitors of Src and Lck protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  21. US 6689782

    Fungal efflux pump inhibitors

    Essential Therapeutics, Inc. · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  22. US 6689877

    Methods and compositions for the treatment of human immunodeficiency virus infection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  23. US 6685626

    Compositions, devices, methods, and kits for induction of adhesions

    Regeneration Technologies, Inc. · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired
  24. US 6685967

    Methods and compositions for pulmonary delivery of insulin

    Nektar Therapeutics · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.